Expression of PIM1 and/or PIM2 is predictive of disease-free, disease-specific and overall survival in non-GCB DLBCL [11, 12] and predominant nuclear PIM1 staining is highly correlated with disease stage in this type [11]. Here, PIM1 is linked to diffuse large B-cell lymphoma.